Gepotidacin
-
Osheroff lab provides mechanistic data in successful FDA application for new gonorrhea treatment
The U.S. Food and Drug Administration has approved the use of the new antibiotic gepotidacin for use against uncomplicated gonorrhea. The biochemistry lab of Neil Osheroff provided all mechanism of action data in the FDA application. Read MoreDec. 11, 2025